SCHEMBL10089103

SCHEMBL10089103

BS(=O)(=O)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL245451 0.70
SCHEMBL42544 0.67
SCHEMBL31424 0.67
SCHEMBL10089100 0.65
SCHEMBL12234848 0.64
SCHEMBL573159 0.64
SCHEMBL11220079 0.64
SCHEMBL42165 0.64
SCHEMBL22930931 0.64
Hydrochloric Acid SCHEMBL6441129 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120094897-A1 NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2012-04-19 US disclosed
WO-2012037259-A1 NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2012-03-22 WO disclosed
US-7423096-B2 Thermally cleavable compound that releases sulfonic acid; thermosetting epoxy resin; curing agents and promoters including an anhydride, a maleamide, a vinyl ether, a cyanate, a phenolic, and/or an amine; thermally activatable fluxes with relatively low vapor pressures at elevated temperatures INTEL CORPORATION (US) 2008-09-09 US disclosed